Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01395550
First received: June 14, 2011
Last updated: August 29, 2011
Last verified: August 2011

June 14, 2011
August 29, 2011
January 2010
July 2010   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01395550 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample

Patients with cardiovascular events

Cardiovascular Events
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
88
July 2010
July 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients who has experienced cardiovascular events

Exclusion Criteria:

  • Patients with no cardiovascular events.
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01395550
NIS-CZA-XXX-2011/1
No
AstraZeneca
AstraZeneca
Not Provided
Not Provided
AstraZeneca
August 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP